Sunday, May 19, 2013 Last update: 5:34 AM
Company Tech News as it Breaks
Intarcia Therapeutics, Inc.
News articles for Intarcia Therapeutics, Inc.:
Thursday, March 21, 2013
- Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 DiabetesBOSTON, March 21, 2013 /PRNewswire/ -- Intarcia Therapeutics, Inc. announced today the enrollment of the first patients in FREEDOM-1, the first of four planned Phase 3 clinical trials studying the safety and efficacy of ITCA 650 (continuous subcutaneous delivery of exenatide) for the treatment ... read more
Tuesday, February 5, 2013
- Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate DevelopmentHAYWARD, Calif., Feb. 5, 2013 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced the appointment of Owen Hughes, Jr., to the position of Chief Business Officer (CBO) and Head of Corporate Development. Mr. Hughes joins Intarcia from Brookside Capital, a multi-billion dollar hedge fund under the Bain ... read more